News about Global Pharma

Zydus Lifesciences Gets USFDA Nod for Phase II(b) Trial of Usnoflast in ALS

Zydus has received USFDA approval to conduct a Phase II(b) clinical trial for Usnoflast, an oral NLRP3 inflammasome inhibitor, in Amyotrophic Lateral Sclerosis (ALS) patients.

Global Pharma | 20/01/2025 | By Manvi |  582

Fermion Partners with Simcere to Develop China's First SSTR4 Agonist Targeting Pain

Guangzhou Fermion Technology and Simcere Pharmaceutical have partnered to develop and commercialise FZ002-037, a clinical-stage SSTR4 agonist for pain management, marking China's first and the world's second selective SSTR4 agonist to reach this stage.

Global Pharma | 20/01/2025 | By Manvi |  659

Glenmark Life Sciences Rebrands its Identity as Alivus Life Sciences

The new identity, Alivus Life Sciences, represents vitality and growth with a renewed focus.

Global Pharma | 20/01/2025 | By Aishwarya |  3322

India Restricts Import of Refurbished Medical Devices Due to Regulatory Gaps

This move highlights India's stringent approach toward medical device regulation, ensuring that only new, certified devices meeting quality and safety standards enter the market.

Global Pharma | 20/01/2025 | By Aishwarya |  606

Freudenberg Medical Announces Appointment of Michael McGee as New CEO

Michael McGee, former COO, assumed the role of Chief Executive Officer, succeeding Dr. Mark Ostwald, who transitioned to another leadership role within the Freudenberg Group.

Global Pharma | 20/01/2025 | By Aishwarya |  276

MalarVx Partners with HDT Bio to Advance repRNA/LION Malaria Vaccine Technology

MalarVx, Inc. has licensed HDT Bio's self-amplifying replicon RNA and LION technologies to develop potent, durable, and cost-effective malaria vaccines.

Global Pharma | 18/01/2025 | By Manvi |  252

Concord Biotech to Use Renewable Energy in its Dholka Facility to Promote Sustainability

Ahmedabad-based pharmaceutical company Concord Biotech will procure 9.9 MW wind-solar hybrid power from Clean Max Enviro Energy Solutions (CleanMax), marking its first investment in renewable energy to power its manufacturing plant at Dholka in Gujarat.

Global Pharma | 18/01/2025 | By Manvi |  661

Mytos Signs Manufacturing Deal with Aspen Neuroscience in Parkinson?s Disease

As part of the partnership agreement, Aspen will integrate Mytos’ iDEM automated cell culture technology into its new manufacturing facility in Torrey Pines, Calif.

Global Pharma | 18/01/2025 | By Aishwarya |  240

SCHOTT Pharma Introduces Next Gen Polymer Syringe System

Developed with SCHOTT Pharma's Alliance to Zero partners, Schreiner MediPharm and Körber Pharma, the system consists of a new cap, a functional label, and a carton packaging.

Global Pharma | 18/01/2025 | By Aishwarya |  377

AstraZeneca Gains CDSCO Nod for Import of Eculizumab in India

Eculizumab is a monoclonal antibody used to treat Paroxysmal Nocturnal Hemoglobinuria (PNH) and Atypical Hemolytic Uremic Syndrome (aHUS) by inhibiting complement-mediated thrombotic microangiopathy.

Global Pharma | 18/01/2025 | By Aishwarya |  380